- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.32 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide(Non-covalent)
- 36 x CL: CHLORIDE ION(Non-functional Binders)
CL.2: 2 residues within 4Å:- Chain A: P.17, R.18
Ligand excluded by PLIPCL.3: 4 residues within 4Å:- Chain A: G.61, Q.63
- Chain F: E.35, K.170
Ligand excluded by PLIPCL.4: 1 residues within 4Å:- Ligands: QNG.1
Ligand excluded by PLIPCL.5: 1 residues within 4Å:- Chain A: R.18
Ligand excluded by PLIPCL.6: 4 residues within 4Å:- Chain A: Q.50, N.53, G.106, Q.114
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain A: E.28, G.60, H.62
Ligand excluded by PLIPCL.10: 2 residues within 4Å:- Chain B: S.16, P.17
Ligand excluded by PLIPCL.11: 3 residues within 4Å:- Chain B: G.61, Q.63
- Chain E: E.35
Ligand excluded by PLIPCL.12: 3 residues within 4Å:- Chain B: P.17, R.18, N.21
Ligand excluded by PLIPCL.13: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.14: 1 residues within 4Å:- Ligands: QNG.9
Ligand excluded by PLIPCL.15: 3 residues within 4Å:- Chain B: Q.50, G.106, Q.114
Ligand excluded by PLIPCL.18: 2 residues within 4Å:- Chain C: P.17, R.18
Ligand excluded by PLIPCL.19: 4 residues within 4Å:- Chain B: E.35, K.170
- Chain C: G.61, Q.63
Ligand excluded by PLIPCL.20: 1 residues within 4Å:- Ligands: QNG.17
Ligand excluded by PLIPCL.21: 1 residues within 4Å:- Chain C: R.18
Ligand excluded by PLIPCL.22: 4 residues within 4Å:- Chain C: Q.50, N.53, G.106, Q.114
Ligand excluded by PLIPCL.23: 3 residues within 4Å:- Chain C: E.28, G.60, H.62
Ligand excluded by PLIPCL.26: 2 residues within 4Å:- Chain D: S.16, P.17
Ligand excluded by PLIPCL.27: 3 residues within 4Å:- Chain A: E.35
- Chain D: G.61, Q.63
Ligand excluded by PLIPCL.28: 3 residues within 4Å:- Chain D: P.17, R.18, N.21
Ligand excluded by PLIPCL.29: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.30: 1 residues within 4Å:- Ligands: QNG.25
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain D: Q.50, G.106, Q.114
Ligand excluded by PLIPCL.34: 2 residues within 4Å:- Chain E: P.17, R.18
Ligand excluded by PLIPCL.35: 4 residues within 4Å:- Chain D: E.35, K.170
- Chain E: G.61, Q.63
Ligand excluded by PLIPCL.36: 1 residues within 4Å:- Ligands: QNG.33
Ligand excluded by PLIPCL.37: 1 residues within 4Å:- Chain E: R.18
Ligand excluded by PLIPCL.38: 4 residues within 4Å:- Chain E: Q.50, N.53, G.106, Q.114
Ligand excluded by PLIPCL.39: 3 residues within 4Å:- Chain E: E.28, G.60, H.62
Ligand excluded by PLIPCL.42: 2 residues within 4Å:- Chain F: S.16, P.17
Ligand excluded by PLIPCL.43: 3 residues within 4Å:- Chain C: E.35
- Chain F: G.61, Q.63
Ligand excluded by PLIPCL.44: 3 residues within 4Å:- Chain F: P.17, R.18, N.21
Ligand excluded by PLIPCL.45: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.46: 1 residues within 4Å:- Ligands: QNG.41
Ligand excluded by PLIPCL.47: 3 residues within 4Å:- Chain F: Q.50, G.106, Q.114
Ligand excluded by PLIP- 6 x IOD: IODIDE ION(Non-functional Binders)
IOD.8: 4 residues within 4Å:- Chain A: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.16: 4 residues within 4Å:- Chain B: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.24: 4 residues within 4Å:- Chain C: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.32: 4 residues within 4Å:- Chain D: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.40: 4 residues within 4Å:- Chain E: G.156, P.157, K.158, E.159
Ligand excluded by PLIPIOD.48: 4 residues within 4Å:- Chain F: G.156, P.157, K.158, E.159
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir. Mbio (2022)
- Release Date
- 2022-07-27
- Peptides
- CAPSID PROTEIN P24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.32 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x QNG: N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide(Non-covalent)
- 36 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bester, S.M. et al., Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir. Mbio (2022)
- Release Date
- 2022-07-27
- Peptides
- CAPSID PROTEIN P24: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B